Quanticate
QCast: Data-Driven Dialogue in Drug Development
QCast by Quanticate is the podcast for biotech, pharma, and life science leaders looking to deepen their understanding of biometrics and modern drug development. Join co-hosts Tom and Jullia as they explore methodologies, case studies, regulatory shifts, and industry trends shaping the future of clinical research. Where biometric expertise meets data-driven dialogue, QCast delivers practical insights and thought leadership to inform your next breakthrough.
Não deixe de visitar o site do podcast e apoiar quem o produz: www.quanticate.com
Autor
Quanticate
Categoria
Site do podcast
Último episódio
20 de nov de 2026
Onde ouvir?
Podcasts no app Replaio Radio Em breveOs podcasts estão chegando ao app. Instale agora e seja o primeiro a descobrir um jeito totalmente novo de curtir podcasts
Episódios
Episode 73: Respiratory Clinical Trials 20.11.2026 9:34
Respiratory clinical trials cover a wide spread of conditions, from asthma and COPD to idiopathic pulmonary fibrosis, chronic cough and Long COVID, and each one asks something different of a study design. In this QCast episode, co-hosts Jullia and Tom look at why endpoints such as FEV1, FVC, exacerbation rates and patient-reported outcomes can’t be swapped for one another. Key Takeaways Design sho...
Episode 72: Group Sequential Designs in Clinical Trials 13.11.2026 9:43
In this QCast episode, co-hosts Jullia and Tom discuss group sequential designs in clinical trials, where pre-planned interim analyses allow a study to stop early for efficacy, stop for futility, or continue to the next look. Key Takeaways Interim looks are usually timed by information fraction, the share of planned statistical information collected so far. A look is only worth including if its re...
Episode 71: What is a Clinical Development Plan? 06.11.2026 11:25
A clinical development plan should connect the evidence a programme needs with its studies, decision points, regulatory interactions and resources. In this QCast episode, co-hosts Jullia and Tom examine how a well-structured CDP turns clinical development strategy into an executable programme, while allowing teams to respond to emerging data without losing scientific discipline. Key Takeaways Each...
Episode 70: Clinical Trial Planning and Design 30.10.2026 10:43
Clinical trial design decisions can have consequences across the protocol, analysis and delivery of a study. In this QCast episode, co-hosts Jullia and Tom examine how a clear research question should guide the study population, endpoints, comparator and statistical approach. Key Takeaways A specific treatment objective helps ensure that the design, endpoint and comparator address the clinical dec...
Episode 69: SDTM Mapping Automation Tool 23.10.2026 10:46
In this QCast episode, co-hosts Jullia and Tom examine how SDTM mapping automation tools use approved rules and metadata to generate mapping specifications and SAS code, and where AI can assist with unfamiliar variables. Key Takeaways Approved mappings can be reused across studies and updated when protocol requirements change, reducing repetitive programming. ML can suggest mappings for unfamiliar...
Episode 68: AI in Clinical Trial Design 16.10.2026 11:26
AI and machine learning can help research teams make more informed clinical trial design decisions, from assessing protocol feasibility to identifying suitable patient populations. In this QCast episode, Jullia and Tom discuss how predictive modelling, natural language processing, and retrospective analysis can support study planning. Key Takeaways AI can help identify restrictive eligibility crit...
Episode 67: The Analysis of Direct and Indirect Pathways in Observational Studies 09.10.2026 12:29
In this episode, Jullia and Tom discuss direct and indirect pathways in observational studies, with a focus on mediation analysis and what it can, and cannot, show. Using an ankylosing spondylitis example, they look at how fatigue, anxiety/depression, and work productivity loss can be mapped as exposure, mediator, and outcome, and why interpretation needs care when the data are observational. Key...
Episode 66: What is Clinical Traceability? 02.10.2026 12:04
Clinical traceability is about being able to follow evidence from a reported result back to its source and understand the transformations, decisions, and records in between. In this QCast episode, co-hosts Jullia and Tom discuss how traceability can become harder when studies involve multiple systems, CROs, laboratories, and technology providers, and why retaining files alone is not enough. Key Ta...
Episode 65: Clinical Trial Trends Shaping Modern Drug Development 25.09.2026 11:36
Clinical trial trends matter most when they affect how studies are designed, delivered, and overseen. In this QCast episode, co-hosts Jullia and Tom discuss how decentralised models, AI, real-world evidence, adaptive designs, RBQM, outsourcing, and digital trial systems are changing practical decisions for sponsors and CROs. Key Takeaways New trial models can reduce participant burden, but they ma...
Episode 64: Tipping Point Analysis in Clinical Trials 18.09.2026 10:13
Tipping point analysis helps trial teams understand how strongly a study conclusion depends on assumptions about missing data. In this QCast episode, co-hosts Jullia and Tom discuss how the method relates to MAR and MNAR, how delta adjustments can identify a tipping point, and why the numerical result still needs clinical interpretation. Key Takeaways Tipping point analysis tests how far assumptio...
Episode 63: Audit Trail Review in Clinical Trials 11.09.2026 10:26
Audit trail review can involve far more than checking whether a system records changes. In this QCast episode, co-hosts Jullia and Tom discuss how trial teams can decide what needs review, where risk should shape scope and timing, and why unusual activity needs context before it becomes a finding. Key Takeaways Audit trail review should focus on relevant risks and questions rather than attempting...
Episode 62: Drug Adherence and Persistence 04.09.2026 10:39
Drug adherence and persistence measures built from claims or EHR databases depend as much on study definitions as recorded treatment events. In this QCast episode, co-hosts Jullia and Tom explain how adherence differs from persistence, what prescribing and dispensing data can and cannot show, and how MPR, PDC, treatment-gap rules and thresholds shape the findings. Key Takeaways Adherence describes...
Episode 61: The Role of Data Monitoring Committees (DMC) in Clinical Trials 28.08.2026 12:28
In this QCast episode, Jullia and Tom discuss the role of data monitoring committees, or DMCs, in clinical trials. They explain how DMCs support participant safety and trial integrity, when independent monitoring may be proportionate, and why confidential interim data needs careful handling. Key Takeaways A DMC provides independent review of accumulating trial data, especially where interim safety...
Episode 60: Oncology Phase 1 Trial Design 21.08.2026 11:22
In this QCast episode, Jullia and Tom discuss how oncology Phase 1 trial design has moved beyond simply identifying the maximum tolerated dose. They look at dose optimisation, escalation methods, simulation, data readiness, expansion cohorts, biomarkers and site capability, with a focus on how these elements affect real dose decisions. Key Takeaways Safety, exposure, pharmacodynamic information, e...
Episode 59: Clinical Data Quality 14.08.2026 10:51
In this QCast episode, Jullia and Tom look at how clinical data quality is shaped from study set-up through collection, review and integration. They discuss why clear definitions, well-designed data flows and proportionate quality control matter, particularly when trial data move across multiple systems or vendors. Key Takeaways Clinical data should be judged by whether they are fit for the decisi...
Episode 58: Rescue Studies 07.08.2026 10:00
In this QCast episode, Jullia and Tom discuss how sponsors can assess a study in difficulty, decide how to handle existing databases and data, manage handovers, and set realistic expectations for recovery. Key Takeaways A rescue assessment should identify the root cause before corrective work begins. Database rescue does not always require a rebuild. Recovery plans need to reflect what can genuine...
Episode 57: Clinical Trial Performance Metrics 31.07.2026 9:27
In this QCast episode, Jullia and Tom examine how clinical trial performance metrics can support better oversight without creating unnecessary reporting burden. They explain the difference between metrics and key performance indicators, why ownership is often shared across sponsors, CROs and sites, and how leading and lagging indicators support different decisions. Key Takeaways Select a focused s...
Episode 56: Bayesian Clinical Trial Design 24.07.2026 9:55
In this QCast episode, co-hosts Jullia and Tom explain how priors, posterior probabilities and predictive probabilities support clinical decisions. They also discuss external data borrowing, adaptive trial features, simulation, regulatory expectations and the operational work needed to deliver interim decisions without weakening trial credibility. Key Takeaways A Bayesian design combines prior inf...
Episode 55: What is Adaptive Trial Design? 17.07.2026 10:27
In this QCast episode, Jullia and Tom examine how adaptive trial design allows pre-specified changes to a clinical trial using accumulating interim data. They look at common adaptations, including early stopping, sample size re-estimation and dose selection, while also addressing the statistical, operational and governance controls needed to protect trial integrity. Key Takeaways Adaptive changes...
Episode 54: SAS vs R vs Python in Clinical Trials 10.07.2026 12:09
In this QCast episode, Jullia and Tom look at SAS vs R vs Python through the lens of clinical trial delivery. Rather than treating the choice as a programming preference, they focus on where each tool tends to fit: SAS for established clinical reporting, R for statistical analysis and visualisation, and Python for automation, integration, and data workflows. Key Takeaways SAS, R, and Python can al...
Episode 53: Decentralised Clinical Trials 03.07.2026 10:52
In this QCast episode, Jullia and Tom discuss decentralised clinical trials and what they mean for clinical development teams in practice. The episode looks at decentralisation as a spectrum of remote, local, digital, and site-based activity, rather than a move to fully virtual trials. Key Takeaways Decentralised clinical trials work best when remote and local activities are selected deliberately....
Episode 52: The Global Statistical Test for Multiple Endpoint Analysis 26.06.2026 9:39
In this QCast episode, Jullia and Tom discuss the Global Statistical Test for multiple endpoints analysis and why it can be useful when a clinical trial needs to assess more than one outcome at the same time. They cover the problem of testing endpoints separately, how GST supports an overall assessment of treatment effect, and why endpoint choice, correlation, missing data, and clinical interpreta...
Episode 51: CDASH Standards and Conformance in Clinical Data Management 19.06.2026 10:18
In this QCast episode, Jullia and Tom discuss CDASH standards and conformance in clinical data management, with a focus on where CDASH sits in the clinical data flow and why it matters before data reaches SDTM. The episode looks at CRF and eCRF design, naming conventions, metadata, controlled terminology, ePRO and eSource data, and the practical problems that can appear when collection standards a...
Episode 50: Multi-Omics Application in Personalised Medicine Studies 12.06.2026 10:48
In this QCast episode, Jullia and Tom discuss multi-omics and its application in personalised medicine studies. The episode explains how genomic, transcriptomic, proteomic, metabolomic and other biological data layers can be analysed together to better understand disease, treatment response and patient subgroups. Key Takeaways Multi-omics brings together several types of biological information to...
Episode 49: BIMO Listings 05.06.2026 10:43
In this QCast episode, Jullia and Tom discuss BIMO listings and their role in FDA inspection readiness. They explain how Bioresearch Monitoring looks at clinical trial conduct, participant protection, data credibility, and the records that support regulatory submissions. The episode also covers common misconceptions, including the idea that BIMO is only a site-level concern, and shows how sponsors...
Podcasts parecidos
O Replaio não é o publicador dos podcasts; os nomes dos programas, as capas e o áudio pertencem aos seus autores e são distribuídos por feeds RSS públicos